Table of Contents

company-logo

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

Cingulate Dividend Announcement

• Cingulate does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Cingulate dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Cingulate Dividend History

Cingulate Dividend Yield

Cingulate current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cingulate stock? Use our calculator to estimate your expected dividend yield:

Cingulate Financial Ratios

P/E ratio-0.00
PEG ratio0.00
P/B ratio0.69
ROE-113174.53%
Payout ratio0.00%
Current ratio7353.85
Quick ratio7353.85
Cash Ratio6.51

Cingulate Dividend FAQ

Does Cingulate stock pay dividends?
Cingulate does not currently pay dividends to its shareholders.
Has Cingulate ever paid a dividend?
No, Cingulate has no a history of paying dividends to its shareholders. Cingulate is not known for its dividend payments.
Why doesn't Cingulate pay dividends?
There are several potential reasons why Cingulate would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cingulate ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cingulate has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cingulate a dividend aristocrat?
Cingulate is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cingulate a dividend king?
Cingulate is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cingulate a dividend stock?
No, Cingulate is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cingulate stocks?
To buy Cingulate you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cingulate stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.